US equities |
NVDA $241.60 ▲+1.13% SPCX $173.82 ▲+1.60% MU $1,065.29 ▲+0.13% AMD $655.33 ▲+3.73% MRVL $291.25 ▲+7.37% SNDK $1,668.56 ▼-2.09% AVGO $378.54 ▲+4.42% TSLA $380.80 ▲+0.55%
FinancialContent

Cencora, Inc. Common Stock (NY:COR)

314.04 -0.89 (-0.28%)
Delayed Quote Updated: 11:59 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Cencora Elects Robert E. Sanchez to Its Board of Directors
From Cencora
Via Business Wire
Cencora (NYSE:COR): A Quality Stock With Strong EBIT Growth and Cash Conversion ↗
Via Chartmill
Cencora (NYSE:COR) Shares Tick Up as Fiscal Q3 Results Meet Estimates, Full-Year Guidance Adjusted ↗
Via Chartmill
News headline image
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 ↗
Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference ↗
Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference... 
Via MarketBeat
News headline image
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 20.35%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
2 S&P 500 Stocks with Exciting Potential and 1 We Question
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its pe... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 19.99%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits. ↗
These healthcare companies can actually benefit from inflation. 
Via The Motley Fool
Topics Bonds Economy Government
News headline image
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
Cardinal Health Earnings: Can Perfection Get Priced In Twice? ↗
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend. 
Via MarketBeat
Topics World Trade
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Cencora (COR) Q3 2026 Earnings Call Transcript ↗
Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds. 
Via The Motley Fool
Topics Earnings
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
Cencora’s second quarter was marked by performance that met Wall Street’s expectations on revenue and exceeded consensus on non-GAAP profitability, driving a... 
Via StockStory
Topics Earnings
News headline image
Cencora Q3 Earnings Call Highlights ↗
Cencora (NYSE:COR) reported fiscal 2026 third-quarter results marked by double-digit adjusted operating income growth, specialty-business momentum and $1 billion in share repurchases, prompting the... 
Via MarketBeat
Topics ETFs Earnings
News headline image
COR Q2 Deep Dive: Specialty Platform and MSO Growth Propel Steady Healthcare Distribution
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA... 
Via StockStory
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA... 
Via StockStory
News headline image
Cencora Reports Fiscal 2026 Third Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Earnings: What To Look For From COR
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Cencora missed analyst... 
Via StockStory
Topics Artificial Intelligence
News headline image
McKesson's Compounding Keeps Adding Up ↗
McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix. 
Via MarketBeat
News headline image
Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Cencora (NYSE:COR) and its pe... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
3 Market-Beating Stocks for Long-Term Investors
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >